Thoughts on fund compensation of adverse events following immunization in China

After the promulgation and implementation of the Vaccine Administration Law of the People’s Republic of China, the compensation of suspected adverse reactions in China is to be reformed and innovated. There have been attempts at compensation through government finance and insurance, but there has be...

Full description

Bibliographic Details
Main Authors: SU Ting, ZHONG Zhilei, YOU Dan, RUAN Litao, YANG Shengran, LI Qian, CHEN Qiuyu, YU Zexu, LI Cheng
Format: Article
Language:zho
Published: Shanghai Preventive Medicine Association 2022-04-01
Series:Shanghai yufang yixue
Subjects:
Online Access:http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.21653
_version_ 1797939248304750592
author SU Ting
ZHONG Zhilei
YOU Dan
RUAN Litao
YANG Shengran
LI Qian
CHEN Qiuyu
YU Zexu
LI Cheng
author_facet SU Ting
ZHONG Zhilei
YOU Dan
RUAN Litao
YANG Shengran
LI Qian
CHEN Qiuyu
YU Zexu
LI Cheng
author_sort SU Ting
collection DOAJ
description After the promulgation and implementation of the Vaccine Administration Law of the People’s Republic of China, the compensation of suspected adverse reactions in China is to be reformed and innovated. There have been attempts at compensation through government finance and insurance, but there has been no precedent for a fund of vaccine-related compensation in China, which means that this could be a new method of solving disputes of compensation for vaccine-related incidences and enhancing public confidence in vaccination. It is suggested that under the current system, we can select a province as a pilot to explore the fund compensation mechanism. The fund comes from special financial allocation, special taxation of vaccine enterprises, fund investment income, charitable donation and other channels. Through a special fund management organization, the independent identification and compensation process can be realized, so as to shorten the current compensation procedure, improve the amount of compensation, ultimately protect the interests of all parties, and promote the steady development of vaccination.
first_indexed 2024-04-10T19:12:23Z
format Article
id doaj.art-9b360decf92940308b73c5e4ed205c4f
institution Directory Open Access Journal
issn 1004-9231
language zho
last_indexed 2024-04-10T19:12:23Z
publishDate 2022-04-01
publisher Shanghai Preventive Medicine Association
record_format Article
series Shanghai yufang yixue
spelling doaj.art-9b360decf92940308b73c5e4ed205c4f2023-01-30T10:53:08ZzhoShanghai Preventive Medicine AssociationShanghai yufang yixue1004-92312022-04-0134438238710.19428/j.cnki.sjpm.2022.216531004-9231(2022)04-0382-06Thoughts on fund compensation of adverse events following immunization in ChinaSU Ting0ZHONG Zhilei1YOU Dan2RUAN Litao3YANG Shengran4LI Qian5CHEN Qiuyu6YU Zexu7LI Cheng8Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaInstitute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, ChinaSchool of Journalism and Communication, Shanghai International Studies University, Shanghai 200083, ChinaAfter the promulgation and implementation of the Vaccine Administration Law of the People’s Republic of China, the compensation of suspected adverse reactions in China is to be reformed and innovated. There have been attempts at compensation through government finance and insurance, but there has been no precedent for a fund of vaccine-related compensation in China, which means that this could be a new method of solving disputes of compensation for vaccine-related incidences and enhancing public confidence in vaccination. It is suggested that under the current system, we can select a province as a pilot to explore the fund compensation mechanism. The fund comes from special financial allocation, special taxation of vaccine enterprises, fund investment income, charitable donation and other channels. Through a special fund management organization, the independent identification and compensation process can be realized, so as to shorten the current compensation procedure, improve the amount of compensation, ultimately protect the interests of all parties, and promote the steady development of vaccination.http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.21653vaccinefundcompensationadverse events following immunization
spellingShingle SU Ting
ZHONG Zhilei
YOU Dan
RUAN Litao
YANG Shengran
LI Qian
CHEN Qiuyu
YU Zexu
LI Cheng
Thoughts on fund compensation of adverse events following immunization in China
Shanghai yufang yixue
vaccine
fund
compensation
adverse events following immunization
title Thoughts on fund compensation of adverse events following immunization in China
title_full Thoughts on fund compensation of adverse events following immunization in China
title_fullStr Thoughts on fund compensation of adverse events following immunization in China
title_full_unstemmed Thoughts on fund compensation of adverse events following immunization in China
title_short Thoughts on fund compensation of adverse events following immunization in China
title_sort thoughts on fund compensation of adverse events following immunization in china
topic vaccine
fund
compensation
adverse events following immunization
url http://www.sjpm.org.cn/article/doi/10.19428/j.cnki.sjpm.2022.21653
work_keys_str_mv AT suting thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT zhongzhilei thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT youdan thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT ruanlitao thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT yangshengran thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT liqian thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT chenqiuyu thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT yuzexu thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina
AT licheng thoughtsonfundcompensationofadverseeventsfollowingimmunizationinchina